Hematology

Explore EBMT 2025 results on transplantation outcomes for Myelodysplastic Syndrome and Acute Myeloid Leukaemia, highlighting survival and relapse data.

Adoptive cell therapy with memory T lymphocytes clears infections in patients that are immunocompromised, showing promising results at EBMT 2025.

Functional respiratory tests may help predict outcomes in anti-CD19 CAR-T cell therapy, as shown in EBMT 2025 research.

Maintenance therapy significantly boosts outcomes for high-risk AML patients after transplantation, as highlighted at EBMT 2025.

A recent study has demonstrated how RNA sequencing can enhance the genetic classification of B cell precursor acute lymphoblastic leukaemia patients…

Reduced-dose apixaban prevents recurrent blood clots in cancer patients, with fewer bleeding complications, offering a safer treatment option.

A groundbreaking study has revealed new insights into the molecular mechanisms that govern the activation and quiescence of haematopoietic stem and progenitor cells.

This nonrandomised study, conducted between 2017 and 2021, involved 201 patients across 43 centres, including both academic and community hospitals.